Risk of giant cell arteritis and polymyalgia rheumatica following COVID-19 vaccination: a global pharmacovigilance study

Rheumatology (Oxford). 2022 Feb 2;61(2):865-867. doi: 10.1093/rheumatology/keab756.
No abstract available

Publication types

  • Letter

MeSH terms

  • Aged
  • COVID-19 Vaccines / adverse effects*
  • Female
  • Giant Cell Arteritis / etiology*
  • Humans
  • Male
  • Middle Aged
  • Pharmacovigilance
  • Polymyalgia Rheumatica / etiology*
  • Risk Factors

Substances

  • COVID-19 Vaccines